SCHEMBL21168977

SCHEMBL21168977

CC(=O)NCC(=O)OC(C)C(=O)OCCCC(=O)OC(C)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.40
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
CRHBP P24387 1/20 0.38
CRHR2 Q13324 1/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
MTNR1A P48039 1/20 0.38
MTNR1B P49286 1/20 0.38
KMT2A Q03164 3/20 0.37
MEN1 O00255 1/20 0.37
OPRM1 P35372 3/20 0.36
HCAR2 Q8TDS4 1/20 0.36
NPC1 O15118 1/20 0.36
LMNA P02545 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TLR2 O60603 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22699878 1.00 ALDH1A1 (0.44) ALDH1A1L3MBTL1CYP3A4CYP2D6CYP2C19
SCHEMBL22705422 0.92 ALDH1A1 (0.44) ALDH1A1L3MBTL1CYP3A4CYP2D6CYP2C19
SCHEMBL22699903 0.88 ALDH1A1 (0.40) ALDH1A1L3MBTL1CYP3A4CYP2D6CYP2C19
SCHEMBL23072531 0.88 ALDH1A1 (0.40) ALDH1A1L3MBTL1CYP3A4CYP2D6CYP2C19
SCHEMBL18669011 0.84 ALDH1A1 (0.45) ALDH1A1L3MBTL1CYP3A4CYP2D6CYP2C19
SCHEMBL18686174 0.80 ADRA1A (0.41) ALDH1A1L3MBTL1KMT2A
SCHEMBL24938343 0.80 ADRA1A (0.41) ALDH1A1L3MBTL1KMT2A
SCHEMBL1054349 0.76 HCAR2 (0.53) ALDH1A1CYP3A4CYP2D6CYP2C19KDM4E
SCHEMBL22699890 0.76 ALDH1A1 (0.44) ALDH1A1L3MBTL1CYP3A4CYP2D6CYP2C19
SCHEMBL22699874 0.75 CTSK (0.39) ALDH1A1CYP3A4CYP2D6CYP2C19KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190218168-A1 PRODRUGS OF GAMMA-HYDROXYBUTYRIC ACID, COMPOSITIONS AND USES THEREOF XWPharma Ltd. (KY) 2019-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190218168-A1 PRODRUGS OF GAMMA-HYDROXYBUTYRIC ACID, COMPOSITIONS AND USES THEREOF GABRB3, GABRB2, GABRB1 ALDH1A1 736/4885L3MBTL1 1789/4885CYP3A4 143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.